You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 96 No. 5, NOVEMBER 1955 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (79)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

External Electric Stimulation of the Heart in Cardiac Arrest

Unexpected Circulatory Arrest

PAUL M. ZOLL, M.D.; ARTHUR J. LINENTHAL, M.D.; LEONA R. NORMAN, M.D.; MILTON H. PAUL, M.D.; WILLIAM GIBSON, M.D.

AMA Arch Intern Med. 1955;96(5):639-653.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Stokes-Adams disease consists of attacks of cerebral ischemia in patients with atrioventricular heart block. The attacks are due to inadequate circulation resulting from very slow idioventricular rhythm, ventricular standstill, ventricular tachycardia, or ventricular fibrillation.1 Their manifestations include dizziness, syncope, prolonged unconsciousness, and convulsions, and they may end in death. At times the attacks may be frequent and severe. If the patient can survive such periods, however, he may live for many years without further episodes.2

Stokes-Adams attacks often require emergency resuscitation, and desperate measures may be necessary. Therapy is complicated by the unpredictable occurrence, frequency, and duration of the seizures. Drugs and cardiac puncture, the only therapy heretofore available, are dangerous and often ineffective.

We have developed a new therapeutic approach to this serious disease: an externally-applied cardiac pacemaker which stimulates the heart electrically, terminates ventricular standstill, and maintains an externally-paced ventricular rhythm for long periods. This approach . . . [Full Text PDF of this Article]


Author Affiliations

Boston

From the Medical Research Department of the Beth Israel Hospital and the Department of Medicine, Harvard Medical School. National Heart Institute Trainee, National Institutes of Health, U. S. P. H. S. (Dr. Paul) and Research Fellow of the American Heart Association (Dr. Gibson).


Footnotes

Submitted for publication July 25, 1955.

Read before the Section on Internal Medicine at the 104th Annual Meeting of the American Medical Association, Atlantic City, June 8, 1955.

Aided by grants from the U. S. Public Health Service, the Patrons of Research of the Beth Israel Hospital, and the Jacob A. Slosberg Memorial Fund of the Massachusetts Heart Association.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1955 American Medical Association. All Rights Reserved.